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Background: Little is known about the relationship between miRNA and mRNA expression in Alzheimer’s disease (AD)
at early- or late-symptomatic stages. Sequence-based target prediction algorithms and anti-correlation profiles have
been applied to predict miRNA targets using omics data, but this approach often leads to false positive predictions.
Here, we applied the joint profiling analysis of mRNA and miRNA expression levels to Tg6799 AD model mice at 4 and
8 months of age using a network topology-based method. We constructed gene regulatory networks and used the
PageRank algorithm to predict significant interactions between miRNA and mRNA.
Results: In total, 8 cluster modules were predicted by the transcriptome data for co-expression networks of AD pathology.
In total, 54 miRNAs were identified as being differentially expressed in AD. Among these, 50 significant miRNA-mRNA
interactions were predicted by integrating sequence target prediction, expression analysis, and the PageRank algorithm.
We identified a set of miRNA-mRNA interactions that were changed in the hippocampus of Tg6799 AD model mice. We
determined the expression levels of several candidate genes and miRNA. For functional validation in primary cultured
neurons from Tg6799 mice (MT) and littermate (LM) controls, the overexpression of ARRDC3 enhanced PPP1R3C
expression. ARRDC3 overexpression showed the tendency to decrease the expression of miR139-5p and miR3470a in
both LM and MT primary cells. Pathological environment created by Aβ treatment increased the gene expression of
PPP1R3C and Sfpq but did not significantly alter the expression of miR139-5p or miR3470a. Aβ treatment increased the
promoter activity of ARRDC3 gene in LM primary cells but not in MT primary cells.
Conclusions: Our results demonstrate AD-specific changes in the miRNA regulatory system as well as the relationship
between the expression levels of miRNAs and their targets in the hippocampus of Tg6799 mice. These data help further
our understanding of the function and mechanism of various miRNAs and their target genes in the molecular pathology
of AD.
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Alzheimer’s disease (AD) is the most common neurode-
generative disease worldwide and is characterized by
cognitive dysfunction and neuronal degeneration [1].
Several pathological markers define AD, including
altered amyloid beta (Aβ) production, Aβ aggregation,
hyperphosphorylated tau, neurofibrillary tangles (NFTs)
and senile plaques [2]. Microtubule-associated protein
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unless otherwise stated.cytoskeleton-related trafficking [3]. Aβ derived from
amyloid precursor protein (APP) is involved in up-regulation
of protein aggregates and related dysfunction in APP
processing resulting from mutations in APP, presenillin1
(PSEN1) or presenillin2 (PSEN2) for early-onset AD and
apolipoprotein E (APOE) for late-onset AD [4].
Omics approaches based on microarray and Next
generation sequencing (NGS) technologies have been
used to study the pathological mechanism of AD [5].
Genome-wide integrative approaches identify functional
drivers of the disease and predict their specific regulatory
functions. Using anti-correlation or target prediction
programs, many studies have focused on the prediction of
target gene or miRNA function; however, this approach. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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interactions and exhibit high noise ratios [6].
In this study, we hypothesized that simultaneous
genome-wide analysis of mRNA and miRNA expression
in an AD model at different disease stages will reveal
differential gene expression patterns in AD, which may
help to predict stage-dependent gene markers in AD
pathology. To this end, we used Tg6799 transgenic mice,
which contain mutant human APP (695) with Swedish
(K670N, M671L), Florida (I716V), and London (V717I)
Familial Alzheimer’s Disease (FAD) mutations, as well as
human PS1 with M146L and L286V FAD mutations [7].
This AD transgenic model has been reported to show
AD-like phenotypes such as rapid accumulation of
Aβ, reduced levels of synaptic marker protein expres-
sion, increased p25 levels, neuronal loss, and memory
impairment [7].
Results and discussion
Module prediction for AD
Using microarray data, we identified three modules
that were closely related with AD. The function of
each module was identified by the GO enrichment
test of DAVID. The miRNA-mRNA interactions in AD
were ranked by their topological importance through our
co-expression network analysis and the ranking scores
were applied to the PageRank algorithm.
In total, 2,197 differentially expressed genes (DEG)
were identified and 8 modules were predicted from theFigure 1 Gene significance scatter plot for several gene modules. Left
correlations and right panel represents the modules with age-related corre
sion and genetic mutation or age was evaluated by Pearson Correlation.expression microarray data. Modules and maturation
factors were predicted using the Pearson Correlation
method (Figure 1). The significance of each module was
calculated using the WGCNA package based on gene
significance (GS) and module membership (MM). Three
modules showed positive correlations with AD (highlighted
in green, pink, and yellow in Figure 1).
The green module showed positive correlation
(cor: 0.64, p: 2.6e-21) with AD for sodium ion transport
(Additional file 1: Table S1). AD has been reported to be
associated with impaired glutamate clearance and
depressed Na+/K+ ATPase levels in the brain [8]. Several
solute carrier family members were found in the green
module (i.e., SLC12a7, SLC12A2, SLC13A4, SLC22A5 and
SLC4A5).
The pink module showed correlations with AD (cor: 0.49,
p: 3.5e-4) and disease stage (cor: −0.56, p: 2.9e-05). Genes
related to ion homeostasis and immune responses were
identified in the pink module (Additional file 1: Table S1).
Metal ion dyshomeostasis is a well-recognized cofactor in
several neurodegenerative disorders [9,10]. In AD, the
process of Aβ misfolding and plaque aggregation is greatly
influenced by alterations in the homeostasis of the afore-
mentioned metal ions [11]. A strong genetic association
between Aβ formation and AD has been reported in several
studies [12] and we found that Aβ is highly expressed in
the AD mouse model used in this study.
The yellow module was correlated with AD (cor: 0.69,
p: 9.3e-42) and included genes related to cell death,panel represents gene scatter plot for the modules with genetic
lations. The statistically significant relationship between gene expres-
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AD is correlated with region-specific neuronal cell loss
[13,14]. Notch 2, found in the yellow module, is known
to regulate the Notch signaling pathway, which is
involved in controlling the fate of neural and non-neural
cells in development process and adults [15]. Several
observations suggest that enhanced Notch signaling and
expression could be instrumental in neurodegeneration
in AD [16]. Huntingtin interacting protein 1 (HIP1), found
in the yellow module, is related to cell death through
caspase-3 activation in immortalized hippocampal
neuroprogenitor cells [17]. Thus, the functions of the
proteins in the green, pink, and yellow modules are
directly associated with AD.
The black, brown and red modules showed relationships
with disease stage and are involved in brain develop-
ment including central nervous system development,
neurogenesis, and forebrain development (Additional file 1:
Table S1). The blue and turquoise modules showed
significant relationships with AD and disease stage.
The gene list for each of the 8 modules and the GSAFigure 2 The subnetwork of weighted coexpression networks of miRN
module genes and related miRNAs. As presented in Figure 1 transgenic plo
subnetwork of green (cor = 0.64) and yellow (cor = 0.69) module genes and
networks. A compact network was constructed from arrestin domain conta
The interaction between miRNA and their target genes were predicted byresults are presented in Additional file 1: Table S1 and
Additional file 2: Table S2.
miRNA-mRNA regulatory network in Tg6799 mice
We constructed a co-expression network from the
functional gene module to study miRNA-mRNA interac-
tions and the regulation of gene expression by miRNA. We
integrated several approaches to predict miRNA targets
and module regulators, which were predicted using 3-target
site analysis. Although black, brown, and yellow modules
did not show direct correlations with genetic AD (Figure 1),
these 3 modules were considered as AD related miRNA
modules because dysregulation of neurogenesis often cause
neurodegenerative diseases. Using all these 6 modules
(black, brown, green, pink, red, and yellow), we calculated
all the pair expression correlations from target relations
using sequence-based target prediction results and selected
254 miRNA-mRNA interactions by anti-correlation.
The constructed co-expression weighted network
(Figure 2) contains the black, brown, red, and pink
modules. mRNAs in the red module correlate significantlyA-mRNA in AD. (A) The subnetwork of brown, grey, and pink
ts (left), these 3 modules show negative correlations. (B) The
related miRNAs. (C) The subnetwork of weighted coexpression
ining 3 (ARRDC3) neighbors and related miRNAs to their target genes.
sequence analysis and expression anti-correlation.
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which interacts with genes in the brown and pink modules,
has been proposed as a key regulator to integrate
age-associated diseases in the vertebrate brain [18-20].
It closely interacted with mRNAs in the brown and
pink modules. Some genes in the disease stage-related
modules have been reported to be associated with AD. For
example, the members of the black and red modules are
related to neurogenesis in normal developmental
stages. The AD network was constructed using the
yellow and green modules (Figure 2). In particular,
miR-142 and miR-338 are known to be down-regulated in
AD patients [21].
Significant interactions of miRNA-mRNA were predicted
by the co-expression network. We assigned priority to
miRNA-mRNA targets based on network topology. We
assumed that highly ranked genes in miRNA-mRNA
networks are more likely to play critical roles in the
pathophysiology of AD. Using the PageRank algorithm,
which is useful for describing the relative node importance
in a network connection, we measured the PageRank
score for miRNA-mRNA interactions and assigned the
rank of interaction priority using only differentially
expressed miRNAs (DEmiR) and DEG. We determined
that 50 miRNA-mRNA interactions were significant
targets and confirmed 19 miRNAs with a high PageRank
score of <0.001 (Additional file 3: Table S3).
Microglia induction in AD can be explained by our
miRNA-mRNA interaction prediction system. Our results
predicted that miR-34b was involved in the regulation of
colony stimulating factor 1 receptor (CSF1R), which has
been reported to be critical for survival and proliferation
of microglia [22]. Our microarray data showed that
CSF1R was significantly down-regulated. Aging and
neurodegeneration seem to be modulated by miR-34
expression through microglial activation [23,24] and
activation of microglial chemokine receptor 1 (CX3CR1)
is known to lead to neuronal death in AD. Our current
microarray data demonstrate that expression of
Chemokine ligand 1 (CX3CL1) and ADAM metallopepti-
dase domain 10 (ADAM10) increased in Tg6799 mice at
8 months of age. ADAM10 is a predicted target of miR-129
and miR-448 and is involved in CX3CL1 cleavage. Cleavage
of CX3CL1 by ADAM10 can lead to microglial activation
of neuronal degeneration [25].
Differential expression of miRNA in Tg6799 mice
In total, 54 differentially expressed (DE) miRNAs were
identified in the early- and late-stage AD mouse model
(cutoff FDR 0.1). We identified several miRNAs that
correlated with AD (Additional file 4: Table S4). For
example, miR-134, which is down-regulated in the brains
of AD mice, is specifically expressed in the brain and has
been demonstrated to negatively regulate dendritic spineformation in vitro [26]. miR-138 is enriched at synapses
and modulate synaptic development and spine size
through the control of acyl-protein thioesterase-1 (APT1)
[27] and the depalmitoylation of G protein alpha 13
(GALPHA13), a down-stream target of APT1, which is an
activator of Rho down-stream of G-protein coupled
receptor (GPCR) [28]. miR-146b is down-regulated in AD
mice and has been reported to be consistently altered in
both hippocampus and medial frontal gyrus in AD mouse
models [21]. miR-146b could be inferred as a negative
regulator of innate immunity and its down-regulation in
the AD brain provides support for an induction of
Toll like receptor (TLR) signaling in AD [21]. miR-222 is
highly expressed in the cortex during early fetal
development and is related to the growth spurt in the
cerebellum compared to the cortex [29]. miR-26a was
observed to be down-regulated in Tg6799 mice at 4
months of age. miR-26a has been reported to be
down-regulated in nasopharyngeal carcinomas and to
suppress cell proliferation and colony formation by
inducing G1-phase cell-cycle arrest [30]. miR-34b and
miR-34c were up-regulated in our AD model mice
and have been reported to be up-regulated in AD patients
[18] (Additional file 4: Table S4).
We validated the expression levels of three miRNAs
(miR139-5p, miR340-5p, and miR3470a) from the list of
candidates. Real time-PCR results showed that at 8
months of age, miR139-5p expression showed tendency
to increase (not significant, p = 0.08), in the hippocampi
of Tg6799 mice compared to littermate controls (Figure 3).
The expression of miR340-5p and miR3470a did not
increase significantly in mutant Tg6799 mice at either
4 or 8 months of age.
Differential expression of mRNA in Tg6799 mice: ARRDC3,
PPP1R3C, Sfpq and metabolic dysfunction
Using integration analysis, we predicted functions of
mRNA and miRNA associations in AD pathology.
Focusing on that many neurodegenerative diseases are
known to be caused by metabolic dysfunction, we
decided to validate our prediction system through
bio-energy metabolism related genes such as arrestin
domain containing 3 (ARRDC3), a predicted target of
miR-340, miR-139, miR-3095 and miR-3470a, in the
brown module (Figures 3 and 2C). To validate the
network topology analysis system, we selected significant
interactions in non-DEmiR and determined the target
gene expression. The mRNA level of ARRDC3 was
increased in the hippocampus of Tg6799 (MT) mice at
4 months of age compared to their littermate (LM)
controls. The mRNA level of ARRDC3 was significantly
increased in an age-dependent manner in the hippocampus
of LM controls (Figure 3). ARRDC3 mRNA also showed
an age-dependent increase in MT mice. Interestingly, we
AB
Figure 3 Verification of the expression of mRNA and miRNA in the hippocampus of Tg6799 mice. (A) The mRNA levels of ARRDC3,
protein phosphatase 1 regulatory subunit 3C (PPP1R3C) and splicing factor, proline- and glutamine-rich (Sfpq) in the hippocampus of Tg6799
mice were verified using RT-PCR. (*: p < 0.05 within littermate (LM) or mutant Tg6799 (MT) mice; §: p < 0.05 between LM or MT mice; §§: p < 0.01
between LM or MT mice). (B) The expression levels of miR139-5p, miR340-5p, and miR3470a in the hippocampus of LM or MT mice were determined
using real-time PCR.
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3C (PPP1R3C) exhibited direct relationships with age or
AD mutation in consequence map data (Figure 3). The
mRNA levels of PPP1R3C increased with age in LM
controls and had a tendency to increase in MT mice at
4 months of age compared to LM controls (Figure 3;
indicated as a red arrow). We determined that mRNA levels
of PPP1R3C and splicing factor proline and glutamate-rich
(Sfpq) decreased with age in MT mice and also decreased
in MT mice at the late symptomatic stage compared to LM
controls (Figure 3; indicated as a blue arrow).We next determined ARRDC3 and Sfpq protein expres-
sion levels by performing semi-quantitative Western blot
analysis using the hippocampus samples from MT mice and
LM controls at 10 months of age. The protein expression
levels of ARRDC3 and Sfpq decreased in MT mice com-
pared to LM controls (Figure 4). Co-immunoprecipitation
data showed direct molecular interaction between ARRDC3
and Sfpq proteins and this interaction was increased in MT
mice compared to LM controls (Figure 4).
ARRDC3 has been implicated in the regulation of
body mass and energy metabolism and plays a role as a
AB
Figure 4 Molecular interaction between ARRDC3 and Sfpq
proteins. (A) The protein levels of ARRDC3 and Sfpq in the
hippocampus of Tg6799 mice were determined using Western blot.
(B) The molecular interaction between ARRDC3 and Sfpq proteins
was detected by co-immunoprecipitation experiment.
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ARRDC3, Sfpq has been implicated in cellular processes
such as transcriptional regulation and RNA splicing, both
of which are related to circadian rhythms. Sfpq is expressed
in neurons and glia and is confined to the nuclei in both
cell types [34]. PPP1R3C could be induced by hypoxia
as a hypoxia induced factor (HIF)-targeted gene. Protein
phosphatase 1 (PP1) is known to target glycogen (PTG)
and to regulate glycogen metabolism [35]. ARRDC3,
PPP1R3C, and Sfpq belong to a metabolism-related
category of genes, as we demonstrated in the brown
module. Previously, Poll et al. demonstrated that arrestin-
dependent GPCR signaling is controlled by rapid
dephosphorylation of PP1 [36].
For functional validation of ARRDC3, we overexpressed
ARRDC3 by transfection or silenced ARRDC3 expression
with siRNA in primary cultured cortical neurons from
Tg6799 (MT) mice and littermate (LM) controls.
ARRDC3 overexpression increased the mRNA levels of
ARRDC3, PPP1R3C, and Sfpq in the cortical neurons of
both LM and MT mice (Figure 5A). After silencing with
ARRDC3 siRNA, the mRNA levels of PPP1R3C and
Sfpq decreased in MT cortical neurons (Figure 5B).
Real time-PCR results showed that miR139-5p and
miR3470a expressions have tendency to decrease after
ARRDC3 overexpression in both LM and MT primarycortical neurons (Figure 5C). We also determined the
length and the number of neurites in primary cultured
neurons from Tg6799 mice using anti-tau antibody.
The number of tau-positive neurons from MT mice
significantly decreased and the length of neurites
decreased as well compared to LM primary neurons.
However, ARRDC3 overexpression could not alter the
length or the number of neurites compared to vehicle
treated MT neurons (Figure 5D).
To determine ARRDC3, Sfpq, and PPP1R3C mRNA
levels and miRNA interaction in Aβ toxic condition, we
administered 2 μM Aβ into the primary cultured cortical
neurons from Tg6799 mice. After Aβ treatment, the
mRNA levels of ARRDC3, PPP1R3C, and Sfpq increased
in the cortical neurons of both LM and MT mice
(Figure 6A). Real time-PCR results showed that after
Aβ treatment, miR139-5p and miR3470a expressions
have tendency to increase in cortical neurons of Tg6799
mice compared to vehicle treated MT neurons (Figure 6B).
To detect luciferase activity of ARRDC3 promoter in toxic
condition, we transfected ARRDC3 promoter into pri-
mary cultured cortical neurons of Tg6799 mice then
administered Aβ. Luciferase activity for ARRDC3 promoter
significantly increased in MT cortical neurons compared to
LM control (Figure 6C). Also after Aβ treatment, luciferase
activity for ARRDC3 promoter significantly increased
in LM cortical neurons compared to vehicle treatment
(Figure 6C).
Taken together, these data suggest that ARRDC3,
PPP1R3C, and Sfpq interact with each other in regu-
lating the age- and disease-specific gene expression of
similar biological pathways such as bioenergetics and
metabolism, which are very strong candidate categories
implicated in the pathophysiological progressive changes
of neurodegeneration [37-40].
Conclusions
Our results demonstrate AD-specific changes in the
miRNA regulatory system and a relationship between the
levels of miRNAs and their targets in the AD hippocampus.
We identified AD-related modules and provided a specific
network that integrates differential miRNA and mRNA
expression profiles. We proposed relevant miRNA-mRNA
target relationships in an AD based on network topological
priorities and miRNA mediated mechanism in AD path-
ology. Our data highlight the functions and mechanisms of
various miRNAs and their target genes in the molecular
pathology of AD including the genes which are related in
ion transport, ion homeostasis, immune responses, cell
death, apoptosis, development, and bio-energy metabol-
ism. Knowledge of candidate genes identified through
the simultaneous genome-wide profiling of miRNA
and mRNA may be useful for the development of future
therapeutics in AD.
Figure 5 Validation of ARRDC3 function in primary cultured cortical neurons from Tg6799 transgenic mice. (A) Overexpression of
ARRDC3 gene in primary cultured cortical neurons from Tg6799 mice. RT-PCR results show that the mRNA levels of PPP1R3C and Sfpq were
increased by ARRDC3 overexpression. (B) Knock-down of ARRDC3 gene in primary cultured cortical neurons from Tg6799 mice. The mRNA levels
of PPP1R3C and Sfpq were decreased by the treatment of ARRDC3 siRNA. (C) Real-time PCR data show that the expression levels of miR139-5p
and miR3470a had decreasing tendency in the primary cortical neurons of Tg6799 mice. (D) Immunocytochemical staining show no significant
enhancement in the number and length of neurites in ARRDC3 overexpressed primary cortical neurons from Tg6799 mice (§: p < 0.05 between
LM and MT mice).
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Animal Husbandry
Tg6799 transgenic mice were purchased from the Jackson
Laboratory (Bar Harbor, ME) and were housed under a
12-h light–dark cycle with free access to food and
water. Female Tg6799 mice (n = 8 in each group) were
maintained until used for the experiment (4 months
for early symptomatic stage and 8 months of age for late
symptomatic stage). After breeding in an expansion
colony, male Tg6799 transgenic mice were mated with
female littermate mice. The genotype of each mouse was
confirmed by PCR using the DNA from mouse tail
tissue. The mice had free access to food and water. All
animal studies were conducted in accordance with
IACUC guidelines and were approved by the IACUC
committee at Hanyang University (HY-IACUC-09-017).
RNA Sample preparation
RNA samples were isolated from the hippocampus
(HC) using TRI-Reagent (Sigma-Aldrich, St. Louis, MO)according to the manufacturer’s instructions. The total
RNA pellet was dissolved in nuclease-free water and RNA
quality and quantity were assessed by Agilent Bioanalyzer
2100 analysis (Agilent, Santa Clara, CA). RNA with RNA
Integrity Number (RIN) above 8 was used for microarray
and sequencing. Gene expression was analyzed with
GeneChip® Mouse Genome 430 2.0 Arrays (Affymetrix,
Santa Clara, CA), which comprises over 45,000 probe sets
representing approximately 28,700 well-characterized mouse
genes. For each gene, eleven pairs of oligonucleotide
probes were synthesized in situ on the arrays.
mRNA microarray hybridization and analysis
Biotinylated cRNA were prepared from 250 ng total
RNA according to the standard Affymetrix protocol
(Expression Analysis Technical Manual, 2001, Affymetrix).
Following fragmentation, 15 μg of RNA were hybridized
for 16 hr at 45°C on a GeneChip Mouse Genome Array.
GeneChips were washed and stained in the Affymetrix
Fluidics Station 450. GeneChips were scanned using the
A B
C
Figure 6 Determination of the expression of ARRDC3 related mRNA/miRNA under A administration. (A) RT-PCR show that the mRNA
levels of ARRDC3, PPP1R3C and Sfpq were increased by Aβ administration in primary cultured cortical neurons of Tg6799 mice. (B) Real time PCR
show that the expression levels of miR139-5p and miR3470a were not significantly altered by Aβ administration in primary cortical neurons from
Tg6799 mice. (C) Luciferase activity of ARRDC3 promoter increased after Aβ treatment in LM cortical neurons but not in MT neurons.
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samples were normalized by the RMA method of R affy
package [41]. DEG testing was accomplished using
the 4 class limma test of 2 mutants and 2 aging factors.
Finally, 2,197 probes were considered to have significantly
differential expression by a cut-off p-value < 0.05.
miRNA sequencing and analysis
RNA quality was assessed by the absence of smear of
18S and 28S bands as analyzed by the Bio analyzer
2100 (Agilent Technologies, Santa Clara, CA). For the
construction of micro RNA libraries, IonTotal RNA-Seq
Kit v2 and Ion Xpress™ RNA-Seq Barcode kit (Life
Technologies, Foster City, CA) were used. The Ion
Total RNA-Seq Kit v2 (Life Technologies) was used
for the preparation of micro RNA libraries according
to the manufacturer’s instructions starting with
100 ng total RNA. The template was prepared from
the libraries using the Ion OneTouch™ System (Life
Technologies) and sequenced on an Ion PGM™
Sequencer (Life Technologies). Total read counts are
shown in Additional file 5: Table S5. As a preprocessing
step, the sequencing adapter was trimmed and read to be
over the range of miRNA length (18–30 nucleotides) were
excluded. We allowed bowtie2 with options of one
mismatch and used mouse miRbase ver. 19 as a reference.
[42,43]. After alignment, a total of 527 miRNAs wereidentified. Raw level data from the miRNA read
count were normalized using the quintile method
and considered as miRNA expression. Differentially
expressed miRNA (DEmiR) was also tested using
limma-like microarray conditions. Finally 54 DEmiRs
were detected within a cutoff p-value ≤ 0.1.
Gene expression network for miRNA target integration
For the genome wide study, we detected gene set
modules from DEG and built a weight co-expression
network. The network was constructed using WGCNA R
packages with 2,197 DEGs from the limma test [44]. We
detected 9 modules with block-wise module function. To
evaluate significant modules related to the sample traits of
AD mutation and aging, we performed scatter plots and
correlations of gene significance and MM were measured.
MM is a quantitative measure for the correlation of the
module eigengene with the gene expression profile. MM
and correlation allow quantification of gene member
similarity for each module. We selected 8 significant
modules using these correlations. The grey module was
removed because of the small gene set count (27 probes,
23 identified genes). Finally for constructing a weighted
network, a topological overlap measure (TOM), as a
measure of the robustness of the network interconnected-
ness, was calculated based on the adjacency matrix from
the 8 module gene set. From module TOMs with a
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was exported to Cytoscape. Functional enrichment of
each module was verified using the DAVID database
(p-value < 0.1) [45].
An integrative network of miRNAs and genes was
constructed after miRNA-target gene prediction. miRNA
and target relationships were predicted by both expres-
sional and sequential analysis. All miRNAs were con-
sidered for miRNA-target anti-correlated expression.
However, we considered and calculated correlations in
view of sample subsets in AD factors or aging factors.
Additionally, the sequence-based target relation was pre-
dicted using both TargetScan and miRAN.org [46,47].
miRNA priority was calculated using the PageRank
algorithm to consider topological importance [48]. From
the sequence and expression-based approaches, we removed
insignificant miRNA and target gene relationships and
ranked miRNA importance by PageRank score. The raw
data were uploaded into the gene expression omnibus
(GEO) database with an accession number of GSE52023.
RT-PCR
The SuperScript III First-Strand Synthesis System (Invitrogen,
Carlsbad, CA) was used to synthesize first-strand cDNA
from an equal amount (500 ng) of RNA. The following
primer sequences were used for RT-PCR in this study:
arrestin domain containing 3, 5′ -TTCTCAGTTTGCCC
CTCGTC- 3′ (forward) and 5′ -TCCTCTGCAAACGTG
TCTCC- 3′ (reverse); protein phosphatase 1, regulatory
subunit 3, 5' -ACGATGGAAGTCCTTGGATG- 3' (forward)
and 5' -TCCATGCGCCTTAATTCTTC- 3' (reverse); splicing
factor proline/glutamine rich, 5' -ACGATGGAAGTVCTT
GGATG- 3' (forward) and 5' - TCCATGCGCCCTTAATT
CTTC- 3' (reverse); glyceraldehyde 3-phosphate dehydro-
genase, 5′-AGAACATCATCCCTGCATCC- 3′ (forward)
and 5′ -T CCACCACCCTGTTGCCTGTA- 3′ (reverse).
Protein sample preparation
Protein samples were prepared from the hippocampus in a
homogenization buffer (50 mM Tris-Cl (pH8.0), 150 mM
NaCl, 5 mM EDTA, 1% Triton X-100) containing protease
and phosphatase inhibitors: 10 μg/ml aprotinin, 25 μg/ml
leupeptin, 10 μg/ml pepstatin, 10 μg/ml PMSF. Homoge-
nates were centrifuged at 14,000 g for 30 min at 4°C
and the supernatants were collected and stored at 80°C
before use.
Western blot
Equal amounts (10 μg) of protein sample were used for
western blot analysis [49]. Protein samples were loaded
in 10% sodium dodecyl surfate (SDS)–polyacrylamide
gels and transferred to polyvinylidene difluoride (PVDF)
membrane (BIO-RAD, Hercules, CA). The following
antibodies were used for primary antibody reaction:polyclonal anti-ARRDC3 (1:2,000; Abcam, Cambridge,
MA) and polyclonal anti-Sfpq (1:2,000; Abcam, Cambridge,
MA) and for secondary antibody reaction: horseradish
peroxidase (HRP)-linked anti-rabbit (1:2500; Vector,
Burlingame, CA).
Co-immunoprecipitation (Co-IP)
Equal amounts (10 μg) of protein samples were
immunoprecipitated using polyclonal anti-ARRDC3
(1:2,000; Abcam, Cambridge, MA) at 4°C for overnight,
followed by binding anti-ARRDC3 to protein A agarose
(Sigma, St. Louis, MO). Immunoprecipitated protein
expression was confirmed by immunoblotting with used
polyclonal anti-Sfpq (1:2,000; Abcam, Cambridge, MA).
Primary cell culture
Cortex and hippocampus were dissected from the brains
of Tg6799 transgenic mice and their littermate controls
at postnatal day 1 (p1). Neurons were cultured on glass
cover slips or cell culture multi-well plates, both coated
with poly-L-ornithine (Sigma, St. Louis, MO), fibronectin
(Sigma, St. Louis, MO), and laminin (Sigma, St. Louis,
MO). Culture media used was DMEM/F-12 with 10% fetal
bovine serum (FBS, GenDEPOT, San Diego, CA), 100 U/
ml penicillin and 100 μg/ml streptomycin (Sigma, St.
Louis, MO), and 2 mM L-glutamin (Gibco, Carlsbad, CA)
supplemented with 5% B-27 supplement (Gibco, Carlsbad,
CA) and 10 ng/ml bFGF (Invitrogen, Carlsbad, CA) at
densities of 3.63 × 104 cells/cm2.
Knock down or overexpression of ARRDC3
To analyze the role of ARRDC3, we transfected the
primary cells with ARRDC3 cDNA on the 7th day of
primary cell culture. The mammalian expression
vector pCMV6-XL4 was used for the overexpression
of full-length human ARRDC3 cDNA (NM 020801.1)
(Origene Technologies, Inc., Rockville, MD). The plasmid
was transiently transfected with standard calcium-
phosphate preparation. After 24 hr, transfected cells were
administered with 2 μM Aβ for 24 hr. Next, we transfected
the primary cells on the 7th day of cell culture with
ARRDC3 siRNA or scrambled ARRDC3 siRNA as
negative control (data not shown). The sequence for
ARRDC3 siRNA is 5′ -GACACCACUUGCUACCUCA- 3′
and the sequence for scrambled ARRDC3 siRNA is
5′ -ACACUCUAACCGGCUUACC- 3′. The siRNAs were
transfected into the primary cells by Gene-mute siRNA
Transfection Reagent (SignaGene laboratories, Gaithersburg,
MD) for 48 hr, as described by the manufacturer.
ARRDC3 promoter-reporter construction
DNA fragments (−280 bp) upstream of the ARRDC3
gene were PCR-amplified using human SHSY-5Y cell
gDNA as template with following primers [50]:
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AGCTG- 3' (forward) and 5' -ATCTCGGTCTTCACC
TTTCCCAGCACC- 3' (reverse). The PCR fragments
were purified, digested, and cloned into the luciferase
vector pGL3-Basic (Promega, Medison, WI) with KpnI
and XhoI restriction sites.
Transient transfection and luciferase assay
Transfection of ARRDC3 promoter was conducted into
primary cells on the 7th day of culture using the standard
calcium-phosphate preparation. After 24 hr, transfected
cells were administered with 2 μM Aβ for 24 hr, lysed,
then measured for luciferase activity using TD-20/20
luminometer (Turner Designs, Sunnyvale, CA) by injecting
40 μl per tube of a buffer containing 100 mM Tris-Cl
(pH 7.8), 15 mM MgSO4, 10 mM ATP, and 65 μM of
luciferin. All transfections were carried out in triplicate.
Immunocytochemistry
After treatment, the primary cells on coated cover slips were
post-fixed in 4% paraformaldehyde for 10 min. The cells
were blocked for 30 min then incubated with polyclonal tau
(Tau46) antibody (1:500; Cell Signaling, Danvers, MA) for
3 hr. After secondary antibody incubation, the cells were
stained with blue alkaline phosphate substrate solution
(Vector Laboratories Inc., Burilngame, CA) then mounted
on gelatin-coated slides for microscopic analysis. Images
were obtained using a Carl Zeiss microscope (Axio observer,
Oberkochem, Germany). The number of tau-positive cells
was counted from microscopic images and analysis was
performed blindly by two different assessors.
Detection of miRNA expression
RNA samples were extracted from mouse hippocampal
tissue using the miRCURY RNA Isolation Kit (Exiqon,
Woburn, MA) according to the manufacturer’s protocol.
cDNA was synthesized using the Universal cDNA synthesis
kit II (Exiqon, Woburn, MA) and was used as a template
for microRNA real-time PCR using ExiLENT SYBR Green
master mix (Exiqon). The following primers were used for
real-time PCR in this study: mmu-mir-139-5p, 5' -UCUA
CAGUGCACGUGUCUCCAG- 3'; mmu-mir-340-5p, 5' -U
UAUAAAGCAAUGAGACUGAUU- 3'; mmu0mir-3470a,
5' -UCACUUUGUAGACCAGGCUGG- 3' and RNU5G
control primer (Exiqon, Woburn, MA). Quantitative real-
time PCR was performed for 10 min at 95°C followed by
10 sec at 95°C and 1 min at 60°C for 45 cycles. At the end
of PCR cycles, melting curve analyses were performed for
each PCR product.
Statistical analysis
All statistical analyses were accomplished using SPSS
(version 17; SPSS Inc., IL). Data were objectively compared
using independent-sample T-tests. Differences betweengroups were considered statistically significant when the
p value was less than 0.05.
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